Search tips
Search criteria 


Logo of iaiPermissionsJournals.ASM.orgJournalIAI ArticleJournal InfoAuthorsReviewers
Infect Immun. 2010 April; 78(4): 1417–1425.
Published online 2010 February 1. doi:  10.1128/IAI.01250-09
PMCID: PMC2849395

Bacterial Guanine Nucleotide Exchange Factors SopE-Like and WxxxE Effectors[down-pointing small open triangle]


Subversion of Rho family small GTPases, which control actin dynamics, is a common infection strategy used by bacterial pathogens. In particular, Salmonella enterica serovar Typhimurium, Shigella flexneri, enteropathogenic Escherichia coli (EPEC), and enterohemorrhagic Escherichia coli (EHEC) translocate type III secretion system (T3SS) effector proteins to modulate the Rho GTPases RhoA, Cdc42, and Rac1, which trigger formation of stress fibers, filopodia, and lamellipodia/ruffles, respectively. The Salmonella effector SopE is a guanine nucleotide exchange factor (GEF) that activates Rac1 and Cdc42, which induce “the trigger mechanism of cell entry.” Based on a conserved Trp-xxx-Glu motif, the T3SS effector proteins IpgB1 and IpgB2 of Shigella, SifA and SifB of Salmonella, and Map of EPEC and EHEC were grouped together into a WxxxE family; recent studies identified the T3SS EPEC and EHEC effectors EspM and EspT as new family members. Recent structural and functional studies have shown that representatives of the WxxxE effectors share with SopE a 3-D fold and GEF activity. In this minireview, we summarize contemporary findings related to the SopE and WxxxE GEFs in the context of their role in subverting general host cell signaling pathways and infection.

Colonization, multiplication, and dissemination are the key steps of an infectious cycle. To persist within the hostile in vivo environments, bacterial pathogens utilize sophisticated virulence strategies to subvert and hijack cellular and systemic functions. A common infection strategy used by Gram-negative pathogens involves injection of virulence factors, known as effectors, by the type III secretion system (T3SS) from the bacterial cell directly into the eukaryotic cell (reviewed in reference 26). The injected effectors target different cellular compartments and subvert numerous signaling pathways for the benefit of the invaded or attached bacteria. Due to their essential role in the regulation of key cellular functions, Rho family small G proteins are common targets of T3SS bacterial effectors (reviewed in reference 23).

To date, 22 members of the Rho GTPase family, belonging to the small GTPase protein superfamily, have been identified (54). Cdc42, Rac1, and RhoA, which trigger formation of filopodia, lamellipodia/ruffles, and stress fibers, respectively, are the best characterized (29). The Rho GTPases share a conserved structure, consisting of two flexible domains called switch I and switch II and a phosphate binding loop (P-loop), which together form a Mg2+- and nucleotide-binding pocket (reviewed in reference 22). The small GTPases are modified posttranscriptionally by the addition of a lipid moiety to the C terminus (farnesyl, geranyl, palmitoyl, or methyl), signaled by the carboxy-terminal CAAX motif (55), which targets them to different membranous compartments.

The function of the small GTPases is strictly regulated. By binding the two switch domains and the lipid moiety, the guanine nucleotide dissociation inhibitors (GDIs) prevent membrane localization and maintain the GTPases in an inactive state in the cytosol (35, 59). Small GTPases act as molecular switches, cycling between GTP-bound (active) and GDP-bound (inactive) conformations. Switching on a GTPase is mediated by guanine nucleotide exchange factors (GEFs) that facilitate the exchange of GDP for GTP. The intrinsically low GTP hydrolysis activity of Rho GTPases is greatly increased by interaction with GTPase-activating proteins (GAPs), leading to recycling of the G protein to its GDP-bound, inactive form. The Rho GTPases transmit signals in a GTP-dependent manner by activating and/or recruiting downstream effector proteins to their sites of action (reviewed in reference 38).

Rho GTPases GEFs belong mainly to the Dbl family and contain a catalytic Dbl homology (DH) domain and a pleckstrin homology (PH) domain, which mediates membrane association, modulates the activity of the DH domain, and probably determines substrate specificity (39). The DH domain is involved in the exchange of GDP to GTP by a mechanism called “push and pull.” It interacts specifically with the Rho GTPase switch I and switch II regions, leading to a conformational change and ejection of GDP and Mg2+. This in turn leads to loading with GTP, which is present in the cytosol at a high concentration (72). Loading of Rho GTPase with GTP-Mg2+ triggers the dissociation of the GEF Rho GTPase complex and allows interaction of the latter with its effectors.

In order to subvert the Rho GTPase pathways, pathogenic bacteria inject effector proteins that mimic GEF, GAP, or Rho GDI into eukaryotic cells. For example, Salmonella enterica serovar Typhimurium injects equivalent amounts of the T3SS effector proteins SopE and SptP, which control the activity of Cdc42 and Rac1. Although sharing no sequence or structural similarities with eukaryotic GEFs (56), SopE triggers nucleotide exchange, which induces “the trigger mechanism of cell entry” (32). SopE is then polyubiquitinated and targeted to the proteosome before SptP, which has GAP activity and exhibits much slower degradation kinetics, helping the cell to recover from the SopE-induced membrane ruffling (42).

Recently, Alto et al. (1) assembled several known T3SS effectors into a single family that share the common motif Trp-xxx-Glu (WxxxE). This family originally included Salmonella SifA and SifB, Shigella flexneri IpgB2 and IpgB1, and the enteropathogenic Escherichia coli (EPEC) and enterohemorrhagic E. coli (EHEC) Map. Since the original classification, new family members EspM (3) and EspT (16) were discovered in EPEC, EHEC, and Citrobacter rodentium (Fig. (Fig.1).1). Although initially thought to be Rho GTPase mimics (1), recent structural, biochemical, and functional data show that the WxxxE effectors, like SopE, are Rho GTPases GEFs, which are the focus of this review.

FIG. 1.
SopE-like and WxxxE effectors. Multiple sequence alignment, with hierarchical clustering of IpgB1 and IpgB2 from Shigella flexneri 2a, EspM2 from EHEC O157:H7, EspT from C. rodentium, Map from EPEC E2348/69, the C-terminal, WxxxE-containing motif of SifA ...


Rho GTPase mimicry hypothesis.

In 2006, Alto et al. showed that when expressed ectopically, several of the WxxxE effectors subvert actin dynamics (1). IpgB2 induced formation of stress fibers, Map induced filopodia, and IpgB1 induced formation of membrane ruffles, phenotypes which correspond to those induced by the activated forms of RhoA, Cdc42, and Rac1, respectively (Fig. (Fig.2).2). In order to determine if formation of stress fibers induced by IpgB2 was epistatic to RhoA, the activity of endogenous RhoA was inhibited either by dominant negatives or by the bacterial toxins YopT and C3. Under these conditions, IpgB2-induced stress fiber formation was not affected, suggesting that IpgB2 was acting independently of the small GTPase. Concordantly, IpgB2 was shown to interact with Rho coiled-coil p160 serine/threonine kinase (ROCK) and the RhoA binding motif of the formin mDia, the two canonical RhoA effectors involved in stress fiber formation (1). In vitro ROCK assays showed that IpgB2 directly stimulated the activity of ROCK. Furthermore, inhibition of ROCK by the chemical inhibitor Y-27632 abolished IpgB2-induced stress fiber formation (1). Together, these findings led Alto and colleagues to conclude that IpgB2 acts as a RhoA mimic, triggering the RhoA pathway by directly activating the RhoA effectors ROCK and mDia (1). This mechanism was extended to other WxxxE family members, and in the absence of sequence similarities and structural data, the results from the seminal paper by Alto et al. (1) supported the hypothesis that the WxxxE effectors function as small GTPase mimics.

FIG. 2.
SopE and WxxxE effectors subvert actin dynamics. Serum-starved Swiss 3T3 cells were mock transfected or transfected with the mammalian expression vector pRK5 encoding myc-tagged IpgB2, EspM2 (not shown), Map, IpgB1, EspT, or the catalytic domain of SopE ...

Before the WxxxE effectors were grouped together, Ohya et al. showed that IpgB1 induces formation of membrane ruffles, which was dependent on Rac1 and, to a lesser extent, on Cdc42 (52). A follow-up study by Handa et al. has shown that IpgB1 binds the N-terminal region of the engulfment and motility protein (ELMO) in a manner similar to that of RhoG (30). Formation of membrane ruffles by IpgB1 was dependent on the ability of ELMO to bind the atypical Rac1 GEF Dock180. Cells transfected with truncated ELMO, which cannot bind Dock180, or with Dock180, which cannot bind Rac1, failed to induce formation of IpgB1-dependent membrane ruffles upon Shigella infection (30). Translocation of the ELMO-Dock180 complex to the membrane is mediated by activated RhoG. Likewise, expression of IpgB1 induces translocation of the ELMO-Dock180 complex to the membrane, where it induces membrane ruffles (30). Together, these results led those authors to conclude that IpgB1 activates Rac1 by binding the ELMO-Dock180 bipartite GEF (30). These results extended the mimicry paradigm, as Handa et al. have shown that IpgB1 was mimicking RhoG (30).

The ability of Map to induce formation of filopodia at the EPEC attachment sites during the early stages of infection was originally described by Kenny and coworkers in 2002 (41). Using dominant-negative constructs, Kenny et al. showed that Map induces filopodia in a Cdc42-dependent but Rac1-independent manner. These results were confirmed by Berger et al., who furthermore demonstrated that Map induces activation of Cdc42 (7). Like IpgB2, transfection or translocation of the EspM effectors resulted in formation of stress fibers in a ROCK-dependent manner (3) (Fig. (Fig.2).2). Production of stress fibers by EspM required active RhoA, since inhibition of this GTPase by dominant-negative constructs abolished stress fiber formation (3). Moreover, pulldown experiments have shown that expression of EspM induced activation of RhoA (3). EspT induces formation of membrane ruffles, which are similar in morphology to those induced by IpgB1, and lamellipodia (Fig. (Fig.2)2) (16), which facilitate EPEC invasion (15). The function of EspT was dependent on cellular GTPases, as EspT enriches the GTP-bound cellular fractions of Rac1 and Cdc42 in in vitro pulldown assays, while inhibition of Rac1, and to a lesser extent Cdc42, blocked EspT-induced formation of membrane ruffles, lamellipodia (16), and invasion (15). Despite the similarities between the phenotypes induced by EspT and IpgB1, the mechanisms by which membrane ruffles and lamellipodia are formed by these two WxxxE effectors are distinct, as EspT induces cytoskeletal rearrangements independently of ELMO or Dock180 (16, 30); these results are consistent with the low sequence similarity between IpgB1 and EspT (Fig. (Fig.1).1). Moreover, small interfering RNA (siRNA) and dominant negatives showed that formation of membrane ruffles by EspT is dependent on the Rac1 effector Wave2 (15).

WxxxE structure and function.

The publication of the crystal structure of SifA in complex with the PH domain of its effector SKIP (SifA and kinesin-interacting protein) (51) represents a turning point in our understanding of the WxxxE effectors. SifA and SifB, which, in contrast to the other WxxxE effectors, do not appear to affect actin dynamics, are particular in that they consist of two domains (51). Ohlson et al. have shown that while the N-terminal domain of SifA binds SKIP, the C-terminal domain, harboring the WxxxE motif, contains two three-helix bundles that form a V-shaped structure (51). This structure is surprisingly highly similar to that of SopE (14). The crystal structure of Cdc42 in complex with the biologically active catalytic fragment of SopE (residues 78 to 240) highlighted the mechanism by which SopE mediates guanine nucleotide exchange (14, 32) and, as a result, formation of membrane ruffles (Fig. (Fig.2).2). Although SopE does not share sequence or structural similarity with known eukaryotic GEFs, it locks the switch I and II regions of Cdc42 in the same conformation as that observed in the equivalent regions of Rac1 or Cdc42 bound to the eukaryotic GEF Tiam or Dbs, respectively.

SopE is composed of six α-helices, forming two three-helix bundles arranged in V-shaped fashion. A small two-stranded β-sheet connects the two arms of the V, followed by a peptide segment harboring a GAGA motif. Binding of SopE induces conformational changes in the switch regions of Cdc42, which are due mostly to insertion of the catalytic GAGA motif between switch I and switch II. This leads to exertion of a push-and-pull type movement, which induces the release of the guanine nucleotide. Consistently, replacement of the first glycine in the GAGA motif by alanine abolishes SopE activity in vitro (14). The two GEF homologues of SopE, SopE2 (Salmonella) and BopE2 (Burkholderia pseudomallei), share with SopE a similar catalytic loop sequence and structure, suggesting a common nucleotide exchange mechanism (5, 65, 66, 70). Interestingly, several of the Cdc42-interacting residues of SopE are conserved in SifA. Moreover, although not similar in sequence, the chemical properties of the residues within the putative catalytic loop of SifA are comparable to those found in SopE (51). Nonetheless, despite its similarities with SopE and the ability to bind RhoA, no GEF activity has yet been demonstrated for SifA (4, 51).

Two recent independent reports have shown that several WxxxE effectors are also Rho GTPase GEFs (4, 36). First, Huang et al. demonstrated that Map specifically binds nucleotide-free Cdc42 and is able to induce the release of GDP and the incorporation of GTP (36). Moreover, the crystal structure of Map in complex with Cdc42 showed a structure similar to those of SopE and SifA, which is composed of seven α-helices arranged into one three-helix bundle and one four-helix bundle, forming a V-shaped structure; a putative catalytic loop connects the two V-shaped arms. Furthermore, comparison of the complexes of Cdc42 to Map, SopE, and the human GEF ITSN1 revealed that despite lacking sequence homology, these three GEFs induce similar conformational changes in Cdc42, suggesting a common mechanism of nucleotide exchange. Importantly, although the sequences of the catalytic loops are somewhat different between SopE and Map, it was shown that alanine and glutamine residues cement the interaction of Map with the switch I region of Cdc42 by making a hydrophobic contact and a hydrogen bond, respectively (36). Concordantly, deletion of the catalytic loop or substitution of either of these two residues inhibited the GEF activity of Map in vitro and compromised host signaling functions of Map during infection (36). Furthermore, GEF activity assays using recombinant IpgB1 and IpgB2 have shown that the former triggers nucleotide exchange in Rac1 and, to a lower extent, in Cdc42 (but not in RhoA), while the latter induces strong activation of RhoA and weak activation of Cdc42 and Rac1 (36). This Rho GTPase specificity of the WxxxE effectors appears to be governed by a complementary pairing between residues at the α4-α6 “selective epitope” of the effectors and the β2-3 interswitch strand of the GTPases.

In a parallel study, EspM2 has been shown to bind tightly and irreversibly to RhoA in vitro and to specifically facilitate loading of GTP into purified RhoA (4). Moreover, modeling the structure of EspM2, aided by nuclear magnetic resonance (NMR), showed that it also adopts a SopE-like conformation (4). As it was shown for Map, mutagenesis of the equivalent glutamine within the catalytic loop impaired the ability of EspM2 to induce loading of GTP into RhoA and formation of stress fibers during ectopic expression (4).

Alto et al. have shown that substituting the tryptophan or glutamic acid residues within the WxxxE motif with alanine was detrimental for function (1). As conservative substitutions (replacing the tryptophan and glutamic acid residues with tyrosine and aspartic acid, respectively) in EspM2 did not result in any significant loss of function (3), the conserved W and E residues were hypothesized to have mainly a structural role. Indeed, the 3-D structures of SifA and Map and the EspM2 model have shown that the W and E residues are positioned around the junction of the two three-helix bundles, maintaining the conformation of the putative catalytic loop through hydrophobic contacts with surrounding residues (36, 51). Consistently, an EspM2 W70A was highly unstable (4). Interestingly, although sharing similar 3-D structures with the WxxxE effectors, SopE has neither a W nor an E equivalent (Fig. (Fig.3).3). Nonetheless, taken together, these results show that the WxxxE effectors belong to a large family of bacterial Rho GTPase GEFs, which also includes SopE, SopE2, and BopE2.

FIG. 3.
Structures of SopE and the WxxxE effectors. (A) Overlay of the crystal structure of Map (yellow; Protein Data Bank [PDB] ID: 3gcg) (36), the crystal structure of the WxxxE-containing domain of SifA (green; PDB ID: 3cxb) (51), the model of EspM2 (purple) ...

Regulation of the WxxxE effector activities.

As it is now apparent that the WxxxE effectors, like SopE, are Rho GTPase GEFs, there is a need to discuss this activity in the context of previously published data. For example, Alto et al. (1) have shown that IpgB2 interacts with the RhoA effectors ROCK and mDia. It is possible that by binding simultaneously, the Rho GTPase and its effector IpgB2 amplify the transmitted signal, as was shown for eukaryotic GEFs (37). This might suggest a mechanism of nucleotide exchange by the WxxxE effectors involving formation of a tripartite complex consisting of GEF Rho GTPase effectors, as was suggested for EspM2 (4). Handa et al. have shown that IpgB1 forms a complex with ELMO Dock180, which is essential for activation of Rac1 in vivo (30). Furthermore, Map contains a carboxy-terminal PSD-95/Disk-large/ZO-1 (PDZ)-binding motif (DTRL), which mediates interaction between Map and PDZ1 of the scaffold protein sodium/hydrogen exchanger regulatory factor 1 (NHERF1) (1, 63). Alto et al. have shown that depleting cells of NHERF1 abolished Map-induced filopodium formation (1), while Simpson et al. (63) have shown that cells infected with EPEC expressing MapΔTRL exhibited no filopodia at 30 min postinfection. Recently, Berger et al. have shown that maintenance of filopodia on the cell surface is dependent on the Map PDZ-binding motif, ezrin, and the RhoA/ROCK pathway (7). These results suggest that the intrinsic GEF activity of these effectors is regulated by formation of large signaling complexes, as also described for few eukaryotic GEFs, which were linked to the activation of Rho GTPases in distinct cellular localizations and pathways (6, 60, 71).


SopE and the WxxxE effectors are central to EPEC, EHEC, Shigella, and Salmonella infection, as they control cell invasion, intracellular survival, and modulation of the host immune responses (summarized in Fig. Fig.4).4). Most of these activities are dependent on the GEF activity of these effectors.

FIG. 4.
SopE-like and WxxxE bacterial effectors subvert host-cell pathways. Using the T3SS, Shigella (A), EPEC/EHEC (B), and Salmonella (C) inject the effectors IpgB1/IpgB2, EspT/Map/EspM, and SopE/SopE2/SifA/SifB, respectively. Except for SifA and SifB, these ...

SopE-like and WxxxE effectors—invasion and intracellular survival.

The virulence strategy used by Shigella and Salmonella involves invasion of enterocytes and macrophages. To invade nonphagocytic cells, Shigella and Salmonella use their T3SSs to deliver effectors, which subvert actin dynamics, leading to formation of membrane ruffles and macropinocytic pockets. Shigella invasion is dependent on T3SS effectors IpgB1, IpaC, IpaA, VirA, and IpgD (49, 68, 69, 73), while Salmonella invasion requires several SPI-1 effectors, including SopE, SopE2, and SopB (5, 32, 50). Cell invasion by B. pseudomallei is mediated by BopE (66).

In addition to playing a role in invasion, SopE has been suggested to affect intracellular bacterial survival by promoting fusion between the Salmonella-containing vacuole (SCV) and early endosomes via recruitment and activation of the GTPase Rab5 (45). The SPI-2 effector SifA plays an important role in intracellular survival and virulence (8), while little is currently known of the function of SifB (9, 24). SifA contains a carboxy-terminal CAAX motif, commonly found in the small GTPases, which when prenylated, facilitates membrane localization and activity (9, 53). SifA is involved in formation of the Salmonella-induced filaments (Sifs), which play a role in maintaining the integrity of the SCV (8, 58, 64). To achieve this, SifA controls membrane dynamics and finely coordinates the equilibrium between the molecular motors kinesin and dynein. Indeed, by binding the host protein SKIP, SifA inhibits recruitment of kinesin to the SCV (10), while by interacting with activated Rab7, it inhibits recruitment of dynein (33). The role played by the WxxxE domain of SifA in these activities is not currently known.

In contrast with the other bacteria encoding SopE or the WxxxE effectors, the attaching and effacing (A/E) pathogens EPEC, EHEC, and C. rodentium were considered to be exclusively extracellular, although sporadic reports have shown that atypical EPEC strains can invade nonphagocytic cells (21, 34). This invasive ability has been linked to the adherence pattern and tight association of EPEC with the host cell membrane, which was hypothesized to produce a passive push effect, leading to internalization. Recently, EspT has been shown to play an analogous role during EPEC and C. rodentium infections to that of IpgB1, SopE, SopE2, and BopE by promoting invasion into nonphagocytic cells via the triggered mechanism. EPEC and C. rodentium invasion requires Rac1 and Wave2 (15). Invaded EPEC resides in an E. coli-containing vacuole (ECV) and induces formation of intracellular actin comets, which appear to promote intracellular replication/survival (15). Screening for the presence of espT among clinical EPEC and EHEC strains has shown that it is a rare effector present only in 1.8% of the EPEC strains and missing from all the O157 and non-O157 EHEC isolates (2). EspT defines a new rare category of invasive EPEC (15).

SopE-like and WxxxE effectors—modulation of host responses.

S. Typhimurium is able to modulate innate immune responses in cultured epithelial cell models independently of the classical TLRs (Toll-like receptors) or NLRs (NOD-like receptors) but via mechanisms involving SopE, SopE2, and SopB (13). By stimulation of the Rho GTPases, these effectors activate the MAP kinase and NF-κB signaling pathways (13). Moreover, in a Cdc42- and Rac1-dependent manner, SopE stimulates caspase-1 activation in vitro, which is needed for induction of mucosal inflammation in vivo (46). Similar to SopE, the WxxxE effectors are Rho GTPase GEFs that might also modulate innate immune response. Indeed, activation of Rac1 by the IpgB1-ELMO-Dock180 complex increases the cellular level of phosphorylated JNK, a MAP kinase involved in host responses (30). Moreover, a recent study by Fukazawa et al. (25) suggested that IpgB2, and to a minor extent IpgB1, activates NF-κB. IpgB2 was shown to activate NF-κB via a unique pathway involving GEF H1, RhoA, and NOD1.

SopE-like and WxxxE effectors—subversion of intestinal barrier functions and diarrhea.

Although other T3SS effectors are involved in disruption of the intestinal barrier functions and alteration of tight junctions (TJ), SopE and the WxxxE family members play an important role in this process.

SopE and SopE2 disrupt TJ structure and function (11). In contrast to wild-type S. Typhimurium, the sopE sopE2 double mutant did not increase the permeability of polarized epithelial cell monolayers and was unable to cause redistribution of ZO-1 and occludin or to alter cell polarity. As these phenotypes are dependent on host protein prenylation (geranylgeranylation), it was suggested that SopE and SopE2 utilize their ability to stimulate Rho family GTPases to disrupt TJ (11).

Recently, EspM2 has been shown to play a role in the disruption of the architecture of the polarized epithelial monolayer (62). Translocation or ectopic expression of EspM2 affected localization of ZO-1 that migrated toward the basal side of the polarized epithelial monolayer. This in turn led to cell rounding and extrusion from the monolayer. However, the TJ alterations induced by EspM2 did not interfere with their functionality; in fact, increased transepithelial electrical resistance (TER) values were observed upon EspM2 expression, suggesting that this effector might play a role in maintaining TJ during infection (62).

Map has been shown to play a role in reducing TER in polarized Caco-2 cells (17, 43), although this was not reproduced in a subsequent study (63). Furthermore, in 2006, Dean et al. reported a role for Map, together with the T3SS effectors EspF, Tir, and intimin, in the effacement of absorptive microvilli and inactivation of the sodium-d-glucose cotransporter (SGLT-1), EPEC phenotypes which are correlated directly with watery diarrhea (18).

In vivo functions of SopE-like and WxxxE effectors.

Despite major advances in our understanding of SopE and the WxxxE effectors in vitro, a complete picture of the function of these effectors in pathogenesis is yet to be obtained. However, several in vivo studies provided some information about the role played by these effectors during infection.

The most dramatic in vivo phenotype associated with a WxxxE family member was observed with a sifA mutant. Consistent with the fact that SifA is required for Salmonella replication in macrophages in vitro, a Salmonella sifA mutant was severely attenuated during single or mixed mouse infections (8, 12, 24, 57). In contrast, a sifB mutant had little effect on virulence (24, 57). Using murine models of intestinal inflammation, it was shown that SopE, and to a lesser extent SopE2, contributes to colitis (31) and virulence (40); SopE2 also induces diarrhea in calves (74). It is worth noting that while SopE is absent from most of the S. Typhimurium isolates, SopE2 is conserved in all pathogenic strains (5, 65). Similar to SopE, BopE has also been shown to play a role in B. pseudomallei virulence, as bopE mutants were attenuated when tested in a mouse model (67).

The role of IpgB2 and IpgB1 in Shigella virulence was investigated using both the Sereny test (61) and the murine pulmonary model (44). An ipgB1 ipgB2 double mutant was highly attenuated, as it did not induce any keratoconjunctivitis and was associated with reduced mortality (28). However, no particular phenotype was associated with a single ipgB2 mutant (28), and the ability of Shigella to induce keratoconjunctivitis using the Sereny test was strongly enhanced in an ipgB1 mutant (28). The precise role of IpgB1 and IpgB2 in pathogenesis in vivo needs to be clarified.

The role played in pathogenesis by Map, and more recently by EspM2 and EspT, has been investigated using the mouse-specific pathogen C. rodentium, the etiological agent of transmissible colonic hyperplasia, commonly used as a model for human EPEC and EHEC infections (reviewed in reference 47). Single-infection studies reported a subtle role for Map in colonization of the mouse colon (19, 48), while a mixed infection of the wild type and the map mutant revealed that the latter is extensively outcompeted (48). In addition, intestinal mitochondrial structure disruption and impaired mitochondrial cellular metabolism observed following C. rodentium infection were shown to be Map dependent (43). Map was reported to have a role in TER disruption in vivo (43), although it had no role in maintaining colon water content at day 7 postinfection (27). However, an independent study which compared stool water content levels in mice colonized at similar levels by wild-type C. rodentium and a map mutant showed higher water content in the former group over a 12-day infection course, suggesting a possible role of Map in diarrhea (63). This phenotype is consistent with binding of Map to NHERFs (63), which regulate ion channel activities. Recently, mouse infections have shown that while a C. rodentium espT mutant did not exhibit a significant difference in terms of bacterial shedding compared to that of wild-type C. rodentium, an espM2 mutant was shed at significantly lower levels and caused less mortality in the highly susceptible CH3/HeJ mouse strain (20).


SopE and the WxxxE effectors constitute examples of convergent evolution in bacterial virulence. Although exhibiting little sequence homology, the WxxxE effectors and SopE share similar structure and function. Their mechanism of nucleotide exchange appears to be similar to that employed by eukaryotic GEFs. While WxxxE effectors can trigger nucleotide exchange in vitro, once translocated, it appears that they function in the context of large signaling complexes, which are likely to regulate their activity. Importantly, while sharing 3-D structure with the other family members and capable of binding RhoA (4, 51), no GEF activity was thus far associated with SifA. Extensive research over many years has shown that SopE and the WxxxE effectors are involved in diverse aspects of infection, including cell invasion, intracellular survival and replication, modulation of host responses, and subversion of the intestinal barrier function (Fig. (Fig.4).4). Contrasting the rapid characterization of the in vitro phenotypes of SopE and the WxxxE effectors, our understanding of their role in virulence is lagging. Translation of the fascinating cell biology surrounding these effectors to pathogenesis is the challenge for future studies.


This work was supported by grants from the MRC (to A.A. and G.F.) and the Wellcome Trust (to R.B., B.R., J.A.G., V.F.C., C.N.B., and G.F.).


Editor: A. T. Maurelli


[down-pointing small open triangle]Published ahead of print on 1 February 2010.


1. Alto, N. M., F. Shao, C. S. Lazar, R. L. Brost, G. Chua, S. Mattoo, S. A. McMahon, P. Ghosh, T. R. Hughes, C. Boone, and J. E. Dixon. 2006. Identification of a bacterial type III effector family with G protein mimicry functions. Cell 124:133-145. [PubMed]
2. Arbeloa, A., M. Blanco, F. C. Moreira, R. Bulgin, C. Lopez, G. Dahbi, J. E. Blanco, A. Mora, M. P. Alonso, R. C. Mamani, T. A. Gomes, J. Blanco, and G. Frankel. 2009. Distribution of espM and espT among enteropathogenic and enterohaemorrhagic Escherichia coli. J. Med. Microbiol. 58:988-995. [PMC free article] [PubMed]
3. Arbeloa, A., R. R. Bulgin, G. MacKenzie, R. K. Shaw, M. J. Pallen, V. F. Crepin, C. N. Berger, and G. Frankel. 2008. Subversion of actin dynamics by EspM effectors of attaching and effacing bacterial pathogens. Cell. Microbiol. 10:1429-1441. [PMC free article] [PubMed]
4. Arbeloa, A., J. Garnett, J. Lillington, R. R. Bulgin, C. Berger, S. M. Lea, S. Matthews, and G. Frankel. 21 December 2009, posting date. EspM2 is a RhoA guanine nucleotide exchange factor. Cell. Microbiol. doi:.10.1111/j.1462-5822.2009.01423.x [PMC free article] [PubMed] [Cross Ref]
5. Bakshi, C. S., V. P. Singh, M. W. Wood, P. W. Jones, T. S. Wallis, and E. E. Galyov. 2000. Identification of SopE2, a Salmonella secreted protein which is highly homologous to SopE and involved in bacterial invasion of epithelial cells. J. Bacteriol. 182:2341-2344. [PMC free article] [PubMed]
6. Bellanger, J. M., C. Astier, C. Sardet, Y. Ohta, T. P. Stossel, and A. Debant. 2000. The Rac1- and RhoG-specific GEF domain of Trio targets filamin to remodel cytoskeletal actin. Nat. Cell Biol. 2:888-892. [PubMed]
7. Berger, C. N., V. F. Crepin, M. A. Jepson, A. Arbeloa, and G. Frankel. 2009. The mechanisms used by enteropathogenic Escherichia coli to control filopodia dynamics. Cell. Microbiol. 11:309-322. [PMC free article] [PubMed]
8. Beuzon, C. R., S. Meresse, K. E. Unsworth, J. Ruiz-Albert, S. Garvis, S. R. Waterman, T. A. Ryder, E. Boucrot, and D. W. Holden. 2000. Salmonella maintains the integrity of its intracellular vacuole through the action of SifA. EMBO J. 19:3235-3249. [PubMed]
9. Boucrot, E., C. R. Beuzon, D. W. Holden, J. P. Gorvel, and S. Meresse. 2003. Salmonella typhimurium SifA effector protein requires its membrane-anchoring C-terminal hexapeptide for its biological function. J. Biol. Chem. 278:14196-14202. [PubMed]
10. Boucrot, E., T. Henry, J. P. Borg, J. P. Gorvel, and S. Meresse. 2005. The intracellular fate of Salmonella depends on the recruitment of kinesin. Science 308:1174-1188. [PubMed]
11. Boyle, E. C., N. F. Brown, and B. B. Finlay. 2006. Salmonella enterica serovar Typhimurium effectors SopB, SopE, SopE2 and SipA disrupt tight junction structure and function. Cell. Microbiol. 8:1946-1957. [PubMed]
12. Brumell, J. H., C. M. Rosenberger, G. T. Gotto, S. L. Marcus, and B. B. Finlay. 2001. SifA permits survival and replication of Salmonella typhimurium in murine macrophages. Cell. Microbiol. 3:75-84. [PubMed]
13. Bruno, V. M., S. Hannemann, M. Lara-Tejero, R. A. Flavell, S. H. Kleinstein, and J. E. Galan. 2009. Salmonella Typhimurium type III secretion effectors stimulate innate immune responses in cultured epithelial cells. PLoS Pathog. 5:e1000538. [PMC free article] [PubMed]
14. Buchwald, G., A. Friebel, J. E. Galan, W. D. Hardt, A. Wittinghofer, and K. Scheffzek. 2002. Structural basis for the reversible activation of a Rho protein by the bacterial toxin SopE. EMBO J. 21:3286-3295. [PubMed]
15. Bulgin, R., A. Arbeloa, D. Goulding, G. Dougan, F. V. Crepin, B. Raymond, and G. Frankel. 2009. The T3SS effector EspT defines a new category of invasive enteropathogenic E. coli (EPEC) which form intracellular actin pedestals. PLoS Pathog. 5:e1000683. [PMC free article] [PubMed]
16. Bulgin, R. R., A. Arbeloa, J. C. Chung, and G. Frankel. 2009. EspT triggers formation of lamellipodia and membrane ruffles through activation of Rac-1 and Cdc42. Cell. Microbiol. 11:217-229. [PMC free article] [PubMed]
17. Dean, P., and B. Kenny. 2004. Intestinal barrier dysfunction by enteropathogenic Escherichia coli is mediated by two effector molecules and a bacterial surface protein. Mol. Microbiol. 54:665-675. [PubMed]
18. Dean, P., M. Maresca, S. Schuller, A. D. Phillips, and B. Kenny. 2006. Potent diarrheagenic mechanism mediated by the cooperative action of three enteropathogenic Escherichia coli-injected effector proteins. Proc. Natl. Acad. Sci. U. S. A. 103:1876-1881. [PubMed]
19. Deng, W., J. L. Puente, S. Gruenheid, Y. Li, B. A. Vallance, A. Vazquez, J. Barba, J. A. Ibarra, P. O'Donnell, P. Metalnikov, K. Ashman, S. Lee, D. Goode, T. Pawson, and B. B. Finlay. 2004. Dissecting virulence: systematic and functional analyses of a pathogenicity island. Proc. Natl. Acad. Sci. U. S. A. 101:3597-3602. [PubMed]
20. Deng, W., C. L. de Hoog, H. B. Yu, Y. Li, M. A. Croxen, N. A. Thomas, J. L. Puente, L. J. Foster, and B. B. Finlay. 24 December 2009, posting date. A comprehensive proteomic analysis of the type III secretome of Citrobacter rodentium. J. Biol. Chem. doi:.10.1074/jbc.M109.086603 [PMC free article] [PubMed] [Cross Ref]
21. Donnenberg, M. S., and J. B. Kaper. 1992. Enteropathogenic Escherichia coli. Infect. Immun. 60:3953-3961. [PMC free article] [PubMed]
22. Dvorsky, R., and M. R. Ahmadian. 2004. Always look on the bright site of Rho: structural implications for a conserved intermolecular interface. EMBO Rep. 5:1130-1136. [PubMed]
23. Finlay, B. B. 2005. Bacterial virulence strategies that utilize Rho GTPases. Curr. Top. Microbiol. Immunol. 291:1-10. [PubMed]
24. Freeman, J. A., M. E. Ohl, and S. I. Miller. 2003. The Salmonella enterica serovar typhimurium translocated effectors SseJ and SifB are targeted to the Salmonella-containing vacuole. Infect. Immun. 71:418-427. [PMC free article] [PubMed]
25. Fukazawa, A., C. Alonso, K. Kurachi, S. Gupta, C. F. Lesser, B. A. McCormick, and H. C. Reinecker. 2008. GEF-H1 mediated control of NOD1 dependent NF-kappaB activation by Shigella effectors. PLoS Pathog. 4:e1000228. [PMC free article] [PubMed]
26. Galan, J. E., and H. Wolf-Watz. 2006. Protein delivery into eukaryotic cells by type III secretion machines. Nature 444:567-573. [PubMed]
27. Guttman, J. A., Y. Li, M. E. Wickham, W. Deng, A. W. Vogl, and B. B. Finlay. 2006. Attaching and effacing pathogen-induced tight junction disruption in vivo. Cell. Microbiol. 8:634-645. [PubMed]
28. Hachani, A., L. Biskri, G. Rossi, A. Marty, R. Menard, P. Sansonetti, C. Parsot, G. T. Van Nhieu, M. L. Bernardini, and A. Allaoui. 2008. IpgB1 and IpgB2, two homologous effectors secreted via the Mxi-Spa type III secretion apparatus, cooperate to mediate polarized cell invasion and inflammatory potential of Shigella flexneri. Microbes Infect. 10:260-268. [PubMed]
29. Hall, A. 1998. Rho GTPases and the actin cytoskeleton. Science 279:509-514. [PubMed]
30. Handa, Y., M. Suzuki, K. Ohya, H. Iwai, N. Ishijima, A. J. Koleske, Y. Fukui, and C. Sasakawa. 2007. Shigella IpgB1 promotes bacterial entry through the ELMO-Dock180 machinery. Nat. Cell Biol. 9:121-128. [PubMed]
31. Hapfelmeier, S., and W. D. Hardt. 2005. A mouse model for S. typhimurium-induced enterocolitis. Trends Microbiol. 13:497-503. [PubMed]
32. Hardt, W. D., L. M. Chen, K. E. Schuebel, X. R. Bustelo, and J. E. Galan. 1998. S. typhimurium encodes an activator of Rho GTPases that induces membrane ruffling and nuclear responses in host cells. Cell 93:815-826. [PubMed]
33. Harrison, R. E., J. H. Brumell, A. Khandani, C. Bucci, C. C. Scott, X. Jiang, B. B. Finlay, and S. Grinstein. 2004. Salmonella impairs RILP recruitment to Rab7 during maturation of invasion vacuoles. Mol. Biol. Cell 15:3146-3154. [PMC free article] [PubMed]
34. Hernandes, R. T., R. M. Silva, S. M. Carneiro, F. A. Salvador, M. C. Fernandes, A. C. Padovan, D. Yamamoto, R. A. Mortara, W. P. Elias, M. R. da Silva Briones, and T. A. Gomes. 2008. The localized adherence pattern of an atypical enteropathogenic Escherichia coli is mediated by intimin omicron and unexpectedly promotes HeLa cell invasion. Cell. Microbiol. 10:415-425. [PubMed]
35. Hoffman, G. R., N. Nassar, and R. A. Cerione. 2000. Structure of the Rho family GTP-binding protein Cdc42 in complex with the multifunctional regulator RhoGDI. Cell 100:345-356. [PubMed]
36. Huang, Z., S. E. Sutton, A. J. Wallenfang, R. C. Orchard, X. Wu, Y. Feng, J. Chai, and N. M. Alto. 2009. Structural insights into host GTPase isoform selection by a family of bacterial GEF mimics. Nat. Struct. Mol. Biol. 16:853-860. [PubMed]
37. Hussain, N. K., S. Jenna, M. Glogauer, C. C. Quinn, S. Wasiak, M. Guipponi, S. E. Antonarakis, B. K. Kay, T. P. Stossel, N. Lamarche-Vane, and P. S. McPherson. 2001. Endocytic protein intersectin-l regulates actin assembly via Cdc42 and N-WASP. Nat. Cell Biol. 3:927-932. [PubMed]
38. Jaffe, A. B., and A. Hall. 2005. Rho GTPases: biochemistry and biology. Annu. Rev. Cell Dev. Biol. 21:247-269. [PubMed]
39. Joseph, R. E., and F. A. Norris. 2005. Substrate specificity and recognition is conferred by the pleckstrin homology domain of the Dbl family guanine nucleotide exchange factor P-Rex2. J. Biol. Chem. 280:27508-27512. [PubMed]
40. Karasova, D., A. Sebkova, V. Vrbas, H. Havlickova, F. Sisak, and I. Rychlik. 2009. Comparative analysis of Salmonella enterica serovar Enteritidis mutants with a vaccine potential. Vaccine 27:5265-5670. [PubMed]
41. Kenny, B., S. Ellis, A. D. Leard, J. Warawa, H. Mellor, and M. A. Jepson. 2002. Co-ordinate regulation of distinct host cell signalling pathways by multifunctional enteropathogenic Escherichia coli effector molecules. Mol. Microbiol. 44:1095-1107. [PubMed]
42. Kubori, T., and J. E. Galan. 2003. Temporal regulation of salmonella virulence effector function by proteasome-dependent protein degradation. Cell 115:333-342. [PubMed]
43. Ma, C., M. E. Wickham, J. A. Guttman, W. Deng, J. Walker, K. L. Madsen, K. Jacobson, W. A. Vogl, B. B. Finlay, and B. A. Vallance. 2006. Citrobacter rodentium infection causes both mitochondrial dysfunction and intestinal epithelial barrier disruption in vivo: role of mitochondrial associated protein (Map). Cell. Microbiol. 8:1669-1686. [PubMed]
44. Mallett, C. P., L. VanDeVerg, H. H. Collins, and T. L. Hale. 1993. Evaluation of Shigella vaccine safety and efficacy in an intranasally challenged mouse model. Vaccine 11:190-196. [PubMed]
45. Mukherjee, K., S. Parashuraman, M. Raje, and A. Mukhopadhyay. 2001. SopE acts as an Rab5-specific nucleotide exchange factor and recruits non-prenylated Rab5 on Salmonella-containing phagosomes to promote fusion with early endosomes. J. Biol. Chem. 276:23607-23615. [PubMed]
46. Muller, A. J., C. Hoffmann, M. Galle, A. Van Den Broeke, M. Heikenwalder, L. Falter, B. Misselwitz, M. Kremer, R. Beyaert, and W. D. Hardt. 2009. The S. Typhimurium effector SopE induces caspase-1 activation in stomal cells to inititate gut inflammation. Cell Host Microbe 6:125-136. [PubMed]
47. Mundy, R., T. T. MacDonald, G. Dougan, G. Frankel, and S. Wiles. 2005. Citrobacter rodentium of mice and man. Cell. Microbiol. 7:1697-1706. [PubMed]
48. Mundy, R., L. Petrovska, K. Smollett, N. Simpson, R. K. Wilson, J. Yu, X. Tu, I. Rosenshine, S. Clare, G. Dougan, and G. Frankel. 2004. Identification of a novel Citrobacter rodentium type III secreted protein, EspI, and roles of this and other secreted proteins in infection. Infect. Immun. 72:2288-2302. [PMC free article] [PubMed]
49. Niebuhr, K., S. Giuriato, T. Pedron, D. J. Philpott, F. Gaits, J. Sable, M. P. Sheetz, C. Parsot, P. J. Sansonetti, and B. Payrastre. 2002. Conversion of PtdIns(4, 5)P(2) into PtdIns(5)P by the S. flexneri effector IpgD reorganizes host cell morphology. EMBO J. 21:5069-5078. [PubMed]
50. Norris, F. A., M. P. Wilson, T. S. Wallis, E. E. Galyov, and P. W. Majerus. 1998. SopB, a protein required for virulence of Salmonella dublin, is an inositol phosphate phosphatase. Proc. Natl. Acad. Sci. U. S. A. 95:14057-14069. [PubMed]
51. Ohlson, M. B., Z. Huang, N. M. Alto, M. P. Blanc, J. E. Dixon, J. Chai, and S. I. Miller. 2008. Structure and function of Salmonella SifA indicate that its interactions with SKIP, SseJ, and RhoA family GTPases induce endosomal tubulation. Cell Host Microbe 4:434-446. [PMC free article] [PubMed]
52. Ohya, K., Y. Handa, M. Ogawa, M. Suzuki, and C. Sasakawa. 2005. IpgB1 is a novel Shigella effector protein involved in bacterial invasion of host cells. Its activity to promote membrane ruffling via Rac1 and Cdc42 activation. J. Biol. Chem. 280:24022-24034. [PubMed]
53. Reinicke, A. T., J. L. Hutchinson, A. I. Magee, P. Mastroeni, J. Trowsdale, and A. P. Kelly. 2005. A Salmonella typhimurium effector protein SifA is modified by host cell prenylation and S-acylation machinery. J. Biol. Chem. 280:14620-14627. [PubMed]
54. Ridley, A. J. 2006. Rho GTPases and actin dynamics in membrane protrusions and vesicle trafficking. Trends Cell Biol. 16:522-529. [PubMed]
55. Roberts, P. J., N. Mitin, P. J. Keller, E. J. Chenette, J. P. Madigan, R. O. Currin, A. D. Cox, O. Wilson, P. Kirschmeier, and C. J. Der. 2008. Rho family GTPase modification and dependence on CAAX motif-signaled posttranslational modification. J. Biol. Chem. 283:25150-25163. [PMC free article] [PubMed]
56. Rudolph, M. G., C. Weise, S. Mirold, B. Hillenbrand, B. Bader, A. Wittinghofer, and W. D. Hardt. 1999. Biochemical analysis of SopE from Salmonella typhimurium, a highly efficient guanosine nucleotide exchange factor for RhoGTPases. J. Biol. Chem. 274:30501-30509. [PubMed]
57. Ruiz-Albert, J., X. J. Yu, C. R. Beuzon, A. N. Blakey, E. E. Galyov, and D. W. Holden. 2002. Complementary activities of SseJ and SifA regulate dynamics of the Salmonella typhimurium vacuolar membrane. Mol. Microbiol. 44:645-661. [PubMed]
58. Salcedo, S. P., M. Noursadeghi, J. Cohen, and D. W. Holden. 2001. Intracellular replication of Salmonella typhimurium strains in specific subsets of splenic macrophages in vivo. Cell. Microbiol. 3:587-597. [PubMed]
59. Scheffzek, K., I. Stephan, O. N. Jensen, D. Illenberger, and P. Gierschik. 2000. The Rac-RhoGDI complex and the structural basis for the regulation of Rho proteins by RhoGDI. Nat. Struct. Biol. 7:122-126. [PubMed]
60. Seipel, K., S. P. O'Brien, E. Iannotti, Q. G. Medley, and M. Streuli. 2001. Tara, a novel F-actin binding protein, associates with the Trio guanine nucleotide exchange factor and regulates actin cytoskeletal organization. J. Cell Sci. 114:389-399. [PubMed]
61. Serény, B., C. Tenner, and P. Rácz. 1971. Immunogenicity of living attenuated shigellae. Acta Microbiol. Acad. Sci. Hung. 18:239-245. [PubMed]
62. Simovitch, M., H. Sason, S. Cohen, E. E. Zahavi, N. Melamed-Book, A. Weiss, B. Aroeti, and I. Rosenshine. 2009. EspM inhibits pedestal formation by EHEC and EPEC and disrupts the architecture of a polarized epithelial monolayer. Cell. Microbiol. doi:.10.1111/j.1462-5822.2009.01410.x [PubMed] [Cross Ref]
63. Simpson, N., R. Shaw, V. F. Crepin, R. Mundy, A. J. FitzGerald, N. Cummings, A. Straatman-Iwanowska, I. Connerton, S. Knutton, and G. Frankel. 2006. The enteropathogenic Escherichia coli type III secretion system effector Map binds EBP50/NHERF1: implication for cell signalling and diarrhoea. Mol. Microbiol. 60:349-363. [PubMed]
64. Stein, M. A., K. Y. Leung, M. Zwick, F. Garcia-del Portillo, and B. B. Finlay. 1996. Identification of a Salmonella virulence gene required for formation of filamentous structures containing lysosomal membrane glycoproteins within epithelial cells. Mol. Microbiol. 20:151-164. [PubMed]
65. Stender, S., A. Friebel, S. Linder, M. Rohde, S. Mirold, and W. D. Hardt. 2000. Identification of SopE2 from Salmonella typhimurium, a conserved guanine nucleotide exchange factor for Cdc42 of the host cell. Mol. Microbiol. 36:1206-1221. [PubMed]
66. Stevens, M. P., A. Friebel, L. A. Taylor, M. W. Wood, P. J. Brown, W. D. Hardt, and E. E. Galyov. 2003. A Burkholderia pseudomallei type III secreted protein, BopE, facilitates bacterial invasion of epithelial cells and exhibits guanine nucleotide exchange factor activity. J. Bacteriol. 185:4992-4996. [PMC free article] [PubMed]
67. Stevens, M. P., A. Haque, T. Atkins, J. Hill, M. W. Wood, A. Easton, M. Nelson, C. Underwood-Fowler, R. W. Titball, G. J. Bancroft, and E. E. Galyov. 2004. Attenuated virulence and protective efficacy of a Burkholderia pseudomallei bsa type III secretion mutant in murine models of melioidosis. Microbiology 150:2669-2676. [PubMed]
68. Tran Van Nhieu, G., A. Ben-Ze'ev, and P. J. Sansonetti. 1997. Modulation of bacterial entry into epithelial cells by association between vinculin and the Shigella IpaA invasin. EMBO J. 16:2717-2729. [PubMed]
69. Tran Van Nhieu, G., E. Caron, A. Hall, and P. J. Sansonetti. 1999. IpaC induces actin polymerization and filopodia formation during Shigella entry into epithelial cells. EMBO J. 18:3249-3262. [PubMed]
70. Upadhyay, A., H. L. Wu, C. Williams, T. Field, E. E. Galyov, J. M. van den Elsen, and S. Bagby. 2008. The guanine-nucleotide-exchange factor BopE from Burkholderia pseudomallei adopts a compact version of the Salmonella SopE/SopE2 fold and undergoes a closed-to-open conformational change upon interaction with Cdc42. Biochem. J. 411:485-493. [PMC free article] [PubMed]
71. Vanni, C., A. Parodi, P. Mancini, V. Visco, C. Ottaviano, M. R. Torrisi, and A. Eva. 2004. Phosphorylation-independent membrane relocalization of ezrin following association with Dbl in vivo. Oncogene 23:4098-4106. [PubMed]
72. Vetter, I. R., and A. Wittinghofer. 2001. The guanine nucleotide-binding switch in three dimensions. Science 294:1299-1304. [PubMed]
73. Yoshida, S., E. Katayama, A. Kuwae, H. Mimuro, T. Suzuki, and C. Sasakawa. 2002. Shigella deliver an effector protein to trigger host microtubule destabilization, which promotes Rac1 activity and efficient bacterial internalization. EMBO J. 21:2923-2935. [PubMed]
74. Zhang, S., R. L. Santos, R. M. Tsolis, S. Stender, W. D. Hardt, A. J. Baumler, and L. G. Adams. 2002. The Salmonella enterica serotype typhimurium effector proteins SipA, SopA, SopB, SopD, and SopE2 act in concert to induce diarrhea in calves. Infect. Immun. 70:3843-3855. [PMC free article] [PubMed]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)